![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 32, 29108-29115, August 9, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, and
From the Laboratoire Neurodégénérescence et
Plasticité, INSERM-UJF (EMI 0108), Hopital A. Michallon, CHU,
BP 217, 38043 Grenoble Cedex 9, France and
Serono
Pharmaceutical Research Institute, 14 chemin des Aulx, 1228 Plan
les Ouates, Geneva, Switzerland
Received for publication, April 25, 2002, and in revised form, May 24, 2002
| |
ABSTRACT |
|---|
|
|
|---|
ALG-2-interacting protein
X (Alix), also known as AIP1, is a cytoplasmic protein
ubiquitously expressed and concentrated in phagosomes and exosomes.
Alix may regulate apoptosis since it binds
apoptosis-linked gene 2 (ALG-2), a
Ca2+-binding protein necessary for cell death, and
also overexpression of its C-terminal half (Alix-CT) blocks death
induced by several stimuli. This part of Alix contains a long
proline-rich domain containing several potential SH3-binding sites.
Using Alix as bait in a yeast two-hybrid system to screen a mouse brain
library, we have found that SH3p4, SH3p8, and SH3p13, collectively
known as endophilins, bind to Alix. Co-immunoprecipitations and overlay experiments allowed us to demonstrate that endophilins bind to Alix-CT
through an SH3/proline-rich domain interaction. We have narrowed the
region of Alix interacting with endophilins down to 14 amino acids
containing a PXRPPPP consensus sequence, also present in
synaptojanin and germinal center kinase-like kinase, allowing their
interaction to endophilins. We further show that overexpression of
Alix-CT, which blocks cell death, leads to cytoplasmic vacuolization
into tubulo-vesicular structures delineated by Alix-CT. This
vacuolization phenomenon is greatly enhanced upon co-expression with
endophilins and may be part of the protecting mechanism afforded by
Alix-CT.
Alix1/AIP1 was first
identified as a protein interacting with the calcium-binding protein
ALG-2 (apoptosis-linked gene 2), which seems necessary for cell death (1, 2). Inhibiting ALG-2
expression protects cells from death induced by several stimuli (3), an
effect similar to that seen upon overexpression of the C-terminal half
of Alix/AIP-1, which contains the ALG-2-interacting domain (4). Even
though Alix and ALG-2 functions remain obscure, these observations have
suggested that both proteins participate in the cell death program.
Alix is a 869-amino acid long cytoplasmic protein that is broadly
conserved throughout species. Rim 20p, a homologue of Alix in
Saccharomyces cerevisiae, was recently shown to interact
with a transcription factor (Rim 101p) and, through SNF7p, with a
cysteine protease (Rim 13p), thereby allowing cleavage of Rim 101p (5). SNF7p/VPS32p is involved in endosomal trafficking (5, 6). Alix
possesses no obvious enzymatic signature, but its last 150 amino acids
are particularly rich in proline (32%), tyrosine, and glutamine
residues and contain several Src homology domain 3 (SH3) binding
motives (PXXP) and two WW binding domains (PPXY). This 150-amino acid-long proline-rich domain (PRD) interacts with the
second SH3 domain of SETA (SH3 domain expressed
in tumorigenic astrocytes), also described as
Ruk (7-9). Expression of the SETA gene is associated with tumorigenic
state in astrocytes. Overexpression of SETA proteins capable of binding
Alix sensitized astrocytes to UV light-induced cell death, whereas
parts of SETA not binding to Alix had no effect (7). Ruk was described
as an adapter protein, forming complexes with the p85 Because the interaction between Alix and SETA/Ruk further suggested a
role for Alix in controlling cell death, we searched for
pathways that may be regulated by Alix. As a first step we screened for
Alix-interacting proteins using a yeast two-hybrid method. We found
that Alix interacts with 3 proteins, SH3p4, SH3p8, and SH3p13, which
all share almost identical SH3 domains and are known as endophilins or
EEN proteins (for review, see Ref. 10). These proteins are known to
regulate membrane shape during endocytosis, possibly through their
lysophosphatidic acid acyltransferase activity (11) or by regulating
enzymes like synaptojanin and dynamin with which they interact through
their SH3 domains (12, 13). We narrowed the site of interaction on Alix
down to a 14-mer peptide, which shows strong homologies to endophilin
binding regions of synaptojanin and of the germinal center kinase-like
kinase (14). We also observed that, when overexpressed, the C-terminal
half of Alix (Alix-CT), which is known to block cell death, induces the
formation of, and accumulates around, a tubulo-vesicular cytoplasmic compartment containing endoplasmic reticulum resident proteins. When
the same Alix-CT is co-expressed with endophilins, the vacuoles/tubules are drastically enlarged and can even form very large spherical vacuoles with a diameter of up to several microns.
Yeast Two Hybrid--
Alix cDNA was cloned into the yeast
expression vector pGBT9 containing the GAL-4 DNA binding domain
(CLONTECH) to be used as bait in a two-hybrid
screen of an adult mouse brain library cDNA
(CLONTECH). The screen was performed in S. cerevisiae Y190 according to the matchmaker two-hybrid system
protocol (CLONTECH). Yeast DNA from positive clones
was recovered and transformed into DH5- SH3 Domain Deletions in SH3p4 and SH3p8--
Coding sequences
for mouse SH3p4 and SH3p8 (accession numbers MMU58886 and MMU58885,
respectively) were PCR-amplified and subcloned into the mammalian
expression vector pCI (Promega) in-frame with the Myc epitope sequence
located to the N terminus. Deletion Variants of Alix--
FLAG-Alix wild type corresponds
to mouse Alix cDNA (MMAJ5073) subcloned into pCI FLAG. Alix-CT and
-NT have been described in Missotten et al. (1).
Alix-CT corresponds to a fragment expanding from amino acid 468 to 869 of Alix, whereas Alix-NT correspond to amino acids 1-434. Both
Alix cDNAs have been subcloned into pCI-FLAG vector. Alix Recombinant Proteins--
The complete coding regions of Alix,
Myc-tagged SH3p4, or Myc-tagged Antibodies--
The polyclonal anti-Alix antibody was raised by
injecting rabbits (Covalab, Lyon, France) with 200 µg of purified
recombinant Alix. IgGs were purified on protein A-Sepharose (Amersham Biosciences).
Anti-Myc and anti-FLAG antibodies were purchased from Santa Cruz
Biotechnology and Sigma, respectively, and the goat anti-mouse horseradish peroxidase-conjugated secondary antibody was from Jackson
Laboratories. Mouse monoclonal antibodies against EEA1 and GM130 were
from Transduction Laboratories. Mouse monoclonal antibodies against
Lamp1 and mtHSP70 were from BD PharMingen and Affinity
Bioreagents, respectively. Mouse Anti-Grp78 monoclonal antibody
against the endoplasmic reticulum (ER) retention signal KDEL
sequence was from StressGen Biotechnologies.
Cell Culture, Transfections--
Human embryonic kidney cells
(HEK 293) were grown in Dulbecco's modified minimal essential medium
(Invitrogen) containing 10% fetal bovine serum. Medium was
supplemented with 10 units/ml penicillin, 10 µg/ml streptomycin, and
2 mM L-glutamine.
For transfections, cells were seeded at 2.5 × 104
cells/cm2 onto plastic or on glass coverslips. The cells
were transfected on the next day using the calcium phosphate
precipitation procedure. Cells were processed for
immunofluorescence or immunoprecipitation 24 or 48 h after transfection.
Immunoprecipitations--
Cells were solubilized in lysis buffer
(142.5 mM KCl, 10 mM Hepes, 0.2% Nonidet P-40,
pH 7.4) containing protease inhibitors (complete, EDTA-free, Roche
Molecular Biochemicals) and centrifuged for 10 min at 20,000 × g. One-third of each lysate was preincubated for 1 h at
4 °C with protein A-agarose beads (Calbiochem). After discarding the
beads, these lysates were incubated overnight at 4 °C with anti-FLAG
monoclonal antibody. Protein A-agarose was then added to the
antibody-containing supernatants and incubated for a further hour at
4 °C. The beads were washed three times with lysis buffer, and bound
proteins were separated on 8% SDS-polyacrylamide gel before transfer
to nylon membrane (Immobilon-P, Millipore). Immunoprecipitated proteins
were detected with an anti-FLAG polyclonal primary antibody, and
co-immunoprecipitated proteins were revealed with an anti-Myc
polyclonal antibody followed by a goat anti-rabbit horseradish
peroxidase-conjugated secondary antibody.
Overlay Assays--
HEK 293 cell lysates and mouse brain
extracts were prepared as described in the previous and following
paragraphs, respectively. Proteins (10 µg/lane) were run on 8%
SDS-polyacrylamide gels and blotted onto nylon membranes. Membranes
were saturated in blocking solution (TBS, 0.1% Tween 20, 5% nonfat
dry milk) for 1 h at room temperature and incubated with 10 µg/ml Myc-tagged recombinant purified protein in blocking solution.
After 2.5 h, membranes were washed in TBS, 0.1% Tween 20, and the
bound recombinant protein was revealed with an anti-Myc monoclonal
antibody followed by a goat anti-mouse horseradish
peroxidase-conjugated secondary antibody.
Two-dimensional Gel Electrophoresis--
Adult mouse brain was
homogenized in lysis buffer (5 mM MgCl2, 50 mM NaCl, 20 mM Hepes, pH 7.2, 0.05% Tween 20, 1 mM dithiothreitol, protease inhibitors EDTA-free). The
homogenate was centrifuged at 800 × g for 20 min at
4 °C, and the supernatants were further centrifuged at 100,000 g for 1 h at 4 °C. Cytosolic protein concentration was determined by the BCA method (Pierce).
Two hundred µg of these proteins were diluted in rehydration buffer
(8 M urea, 4% CHAPS, 40 mM Tris base, 20 mM spermine, 50 mM dithiothreitol, 0.5%
immobilized pH gradient (IPG) buffer) and first separated according to
their isoelectric points along non-linear IPG strips, 7 cm long, pH
3-10 (Amersham Biosciences). Sample loading was performed by in-gel
re-swelling. The strips were equilibrated in a solution containing 1%
dithiothreitol for 15 min followed by a solution containing 2.5%
iodoacetamide for 10 min. The proteins were then separated according to
their molecular mass using standard SDS-PAGE.
Immunofluorescence Microscopy--
Cells were washed twice with
PBS and fixed in 4% paraformaldehyde in PBS for 10 min. Cells were
permeabilized with 0.02% saponin in TBS for 30 min and then incubated
for 2 h with the indicated antibodies. Primary antibodies were
revealed with goat anti-mouse or anti-rabbit immunoglobulin G coupled
to Alexa 594 or Alexa 488 (Molecular Probes), diluted in saponin/TBS.
Nuclei were stained using Hoechst 33258 (Sigma). Coverslips were
mounted in Mowiol (Calbiochem) and observed with an Axiovert microscope
(Zeiss) or a confocal laser-scanning microscope LSM 410 (Zeiss).
Two-hybrid Screen for Alix-interacting Proteins--
We set out to
identify and characterize Alix-interacting proteins using a yeast
two-hybrid system. A cDNA encoding full-length Alix was fused to
the DNA binding domain of the GAL4 transcription factor and used to
screen a mouse brain cDNA library fused to the GAL4 activation
domain (the same library as that used to search for ALG-2-interacting
proteins in Missotten et al. (1)). Thirty-two positive
clones were obtained of 4 million transformants. Two identical clones
were found to code for full-length ALG-2. One clone coded for the
C-terminal half of Alix (starting at aa 456), suggesting that this
domain of the protein can form oligomers.
Among 16 other clones, 8 coded for SH3p13 (4 different clones), 5 coded
for SH3p4 (3 different clones), and 3 coded for SH3p8. The three
proteins contain one C-terminal SH3 domain and are collectively known
as endophilins since they are involved in endocytosis and are highly
homologous (68% overall identity), sharing almost identical SH3
domains (16). They are also referred to as SHGL2 and endophilin I for
SH3p4, which is brain-specific, SH3GL1 and endophilin II for SH3p8,
which is ubiquitously expressed, SH3GL3 and endophilin III for SH3p13,
which is expressed in brain and testis (12, 17). All prays obtained
encompass the SH3 domain, with the shortest clone starting at aa 124 for SH3p13, and at aa 155 for SH3p4 and SH3p8. None of the other clones
obtained, which will be described elsewhere, coded for other SH3
domain-containing proteins, suggesting that endophilins are specific
partners for Alix in vivo.
Endophilins Interact with Alix in HEK 293 Cell Lysates and Brain
Extracts--
To verify that the interaction between Alix and
endophilins revealed using the yeast two-hybrid system reflects their
ability to interact in intact cells, we overexpressed different forms of Alix (Fig. 1A) and
endophilins (SH3p4 or SH3p8) in HEK 293 cells and tested for their
interactions by co-immunoprecipitations. Fig.
2 shows the results of such an experiment
using cells transiently co-transfected with expression vectors coding
for Myc-tagged full-length or truncated SH3p8 and for FLAG-tagged
full-length or truncated Alix (Alix-NT and Alix-CT, which correspond to
the N-terminal half and C-terminal half of the protein, respectively
(Fig. 1A)). The overall expression of truncated and
full-length Alix and SH3p8 was monitored in all cell extracts using a
mixture of antibodies to Myc and to FLAG (Fig. 2c). Alix
proteins were immunoprecipitated from these homogenates using an
anti-FLAG monoclonal antibody, and the presence of full-length or
truncated forms of Alix in the blotted immunoprecipitates was verified
using a polyclonal anti-FLAG antibody (Fig. 2b). We used an
anti-Myc antibody to test if Myc-tagged SH3p8 was present in the same
immunoprecipitates. As seen in Fig. 2a, SH3p8 does indeed
co-precipitate with full-length Alix and with Alix-CT, which contains
the PRD but not with the N-terminal half of the protein (Alix-NT).
Binding of SH3p8 to Alix required an intact SH3 domain, as no
endophilin lacking its SH3 domain (
Further evidence for a direct interaction between endophilins and Alix
is brought by overlay experiments; lysates from HEK 293 cells
overexpressing different forms of Alix were run on SDS-PAGE and blotted
onto Nylon membranes. Purified Myc-tagged recombinant SH3p4 was
incubated on the membrane, and its binding was revealed with an
anti-Myc antibody (Fig. 3a).
SH3p4 bound strongly to a protein migrating around 100 kDa in all cell
lysates (gray arrow), which was identified as endogenously
expressed Alix, since it is recognized by the polyclonal anti-Alix
antibody (Fig. 3c). The recombinant endophilin also bound to
overexpressed full-length Alix (black arrow) and to its
C-terminal half but not to its N-terminal half (not shown). The
molecular mass of overexpressed Alix is higher than that of endogenous
Alix due to 26 extra amino acids corresponding to two FLAG tags.
Binding of endophilin to Alix occurs through an SH3/PRD interaction
since (i) Alix
We also used the overlay assay to test if Alix expressed in adult mouse
brain binds to SH3p4. In blotted brain homogenate supernatants, SH3p4
stained 1 band at 150 kDa and 2 doublets migrating at 100 and 75 kDa
(Fig. 4A). This pattern is in
good agreement with that found by McPherson and co-workers (14, 19)
using recombinant GST-endophilin I or endophilin I SH3 domain on brain extracts. Based on molecular masses, they identified within the endophilin-binding proteins, synaptojanin at 145 kDa and dynamin and
germinal center kinase-like kinase, both migrating at 100 kDa. We show
that the lower band of the 100-kDa doublet binding SH3p4 was also
recognized by anti-Alix antibodies (Fig. 4A). The reason for
the slightly higher molecular mass of Alix in brain compared with in
HEK 293 cells is unknown. To further discriminate between 100-kDa brain
proteins binding SH3p4, we performed an overlay assay on brain
homogenates that had been separated on two-dimensional gels (Fig.
4B). In the 100-kDa range, SH3p4 two discrete spots
with an isoelectric point in the range of the theoretical isoelectric
point calculated for Alix (pI 6.15) (Fig. 4B, a). On the same membrane, the polyclonal anti-Alix antibody recognized three spots, the two more acidic co-migrating exactly with those binding SH3p4 (Fig. 4B, b). An antibody against
synaptojanin (a kind gift of P. De Camilli) labeled the upper band
migrating around 150 kDa (not shown). The proteins binding SH3p4, which
migrate in the basic range, have not been identified.
Overexpressed Alix-CT Delineates Tubular Vesicular
Structures--
As described by others, we found that in HEK 293 cells, overexpressed Alix is cytoplasmic and concentrated in the
perinuclear region and at the cell periphery in lamellipodia and
filopodia (Fig. 5A). A similar
distribution was observed with Alix-NT (Fig. 5B). In
contrast, overexpressed Alix-CT containing the endophilin binding
region is concentrated around perinuclear vesicles (Fig. 5,
C, D, and E). These vesicles were also
seen when Alix-CT was overexpressed in 3T3 fibroblasts, NG108
neuroblastoma cells, and post-mitotic cerebellar neurons (not shown).
Using confocal microscopy, we observed that some Alix-CT-induced
vesicles are parts of a tubulo-vesicular network with tubes of 400-800
nm in diameter (Fig. 5D).
To test which intracellular compartments may be affected by Alix-CT, we
examined the distributions of various markers in Alix-CT-transfected cells. The distribution of EEA1, an established marker for early endosomes, Lamp1, a marker for late endosomes and lysosomes, GM130, a
cis-Golgi matrix protein, mtHSP70, a mitochondrial resident protein,
and MitoTracker CMTMRos, a mitochondrial marker, did not significantly
differ between untransfected cells and Alix-CT-transfected cells (not
shown). This suggests that none of these compartments are strongly
affected by Alix-CT overexpression.
In contrast, an antibody recognizing KDEL-bearing proteins, which are
resident proteins of the endoplasmic reticulum lumen, stained around
some of the tubulo-vesicular structures. Therefore Alix-CT may impair
the shape of the endoplasmic reticulum or modify intracellular protein
trafficking (Fig. 5, E and F).
Endophilins Colocalize with Alix and Enhance the Vesicular
Phenotype Induced by Alix-CT--
A further indication that endophilin
interacts with Alix in vivo came from the perfect
co-localization seen with Alix and SH3p4 overexpressed in HEK 293 cells
(Fig. 6, A and B).
Both overexpressed proteins co-localized in cell protrusions like
lamellipodia, filopodia, and in the perinuclear region of the
cytoplasm.
Knowing that the endophilin-binding site lies within Alix-CT, we
performed the same type of experiments as above to verify that Alix-CT
and SH3p4 interact in situ. To our surprise, co-expression of the endophilin seemed to enhance cytoplasmic vacuolization induced
by Alix-CT; staining with anti-Alix antibody revealed perinuclear
vacuoles considerably bigger than those found in cells overexpressing
Alix-CT alone (Fig. 6C). 24-48 h after transfection, 2-10
perinuclear spherical vacuoles delineated by Alix-CT were seen. In most
extreme cases, vacuoles could reach a diameter of up to 6 µm (Fig.
6E). Alix-CT was almost exclusively found around these very
large vacuoles, whereas SH3p4 not only co-localized with Alix-CT but
was also present in the rest of the cytoplasm (Fig. 6, C and
D). As in the case of Alix-CT alone, of all the intracellular markers tested, only anti-KDEL antibodies decorated the
periphery of some of the very large vacuoles, suggesting that some of
these structures may represent endoplasmic reticular membrane or that
intracellular trafficking may be impaired (Fig. 6, F and G).
The "very large vacuole" phenotype requires an intact SH3 domain of
endophilin since Alix-CT co-expressed with
As in the case of Alix-CT tubulo-vesicular structures (Fig. 7,
E and F), Alix-CT/endophilin-induced vacuoles
were resistant to pretreatment of cells with 0.1% Triton X-100 (Fig.
7, G and H). Such a treatment left Alix-CT and
SH3p4 concentrated around the vacuoles, whereas the endophilin was
completely washed away from the rest of the cytoplasm (Fig.
7H). Together these data show that Alix interacts
with endophilins and suggest that it modifies intracellular
compartmentalization, a function synergized by endophilins.
By using Alix as bait in a yeast two-hybrid screen, we found that
it binds to SH3 domain-containing proteins, a result that was
predictable in view of the multiple potential SH3 binding motives of
the long Alix PRD. More surprising to us was the specificity of the
interaction, since endophilins which are identical within their
SH3 domains were the only SH3-containing proteins found in our screen.
However, we did not find SETA/Ruk, previously described to bind to Alix
PRD (7). This could be because the SH3 domain of SETA/Ruk interacting
with Alix lies within the first 151 amino acids of the 665-aa-long
protein (9) and may be only rarely represented in the mouse brain
library made of oligo-dT-primed inserts. Also surprising to us was the
results of overlay assays suggesting that in HEK 293 cells and in brain
Alix is the main endophilin interactor. Indeed, endophilins are known
partners of metalloprotease disintegrins MDC5 and MDC 9 and of the
The polyphosphoinositide phosphatase, synaptojanin, is involved in
different steps of endocytosis, and free clathrin-coated vesicles
accumulate in living lamprey synapses microinjected with a peptide
blocking the SH3 domain of endophilin (18). This peptide, PP19, lying
within the synaptojanin PRD is homologous to the endophilin-binding site of germinal center kinase-like kinase (14) and MDC9 (20) and also
to 14 amino acids of Alix PRD (aa 748-761) (Fig. 1B). This
Alix peptide contains the endophilin-binding site with a consensus
PXRPPPP conserved in Xenopus and in
Caenorhabditis elegans, reminiscent of the endophilin III
binding motif PXRPPXPR that Cesareni and
co-workers (23) define using recombinant peptides.
Interaction between Alix-CT and Endophilin Deforms Intracellular
Membranes--
In our case, neither overexpression of Alix nor of
Alix-CT, which both contain the endophilin-interacting site, had any
detectable effect on dextran- or clathrin-mediated transferrin
endocytosis (not shown). This lack of effect may suggest that Alix
could interact and regulate endophilins not at the plasma membrane but
in cytoplasmic compartments. Recently, Farsad et al. (24)
demonstrate that endophilin B, a protein with homology to endophilin 1, is localized to the Golgi complex, thereby underscoring a potential
role of endophilin family members in diverse tubulo-vesicular
membrane-trafficking events in the cell. This hypothesis is in good
agreement with our finding that overexpression of Alix-CT leads to
accumulation of perinuclear tubulo-vesicular structures, which were
transformed into a few very large vacuoles upon co-expression with
endophilins. Overexpressing endophilins alone had no vacuolization
effect, and endophilin lacking the SH3 domain did not synergize with
Alix-CT. Furthermore, Alix-CT devoid of its PRD region and, therefore, unable to interact with endophilins had no vacuolating effect in HEK
293 cells. Our current hypothesis is that Alix-CT deforms intracellular
membranes by interacting with and modifying the activity of
endogenously expressed endophilin and that increasing the expression of
endophilin further enhances this phenomenon. The intracellular
membrane-deforming activity may be due to the lysophosphatidic
acid-acyltransferase activity described for endophilin I, which may
modify membrane curvature (10, 11). Recently, Farsad et al.
(24) also show that recombinant SH3p4 binds directly to liposomes,
deforming them into tubules with diameters of 20-100 nm. It will now
be of interest to test if recombinant Alix-CT can activate endophilin
in the liposome assay described above or if it can affect its
lysophosphatidic acid-acyltransferase activity.
It has been difficult to determine precisely which intracellular
compartment Alix-CT and endophilins do affect. Proteomic studies
demonstrate that Alix is highly enriched in phagosomes (25) and in
exosomes, these latter originating from multi-vesicular bodies that are
intermediates between early and late endosomes (26). In our hands,
neither early nor late endosomes were drastically affected by Alix-CT
and endophilin overexpression. A marker of ER resident proteins (KDEL)
was distributed around some Alix-CT/endophilin-induced tubulo-vesicular
structures and vacuoles, suggesting that Alix-CT overexpression leads
to swelling of parts of the ER or impairs trafficking of some ER
proteins. Interestingly, the Alix-CT/endophilin-delineated structures
induced by the overexpression were resistant to Triton-X100. Because we
have not found any abnormal cholesterol concentration in
Alix-CT-stained compartments (not shown), we favor the hypothesis that
the resistance to detergent is due to Alix-CT and endophilins being
caught in a mesh of cytoskeletal proteins stabilizing the tubules and vacuoles.
Protective Effect of Alix-CT in Cell Death--
Overexpression of
the C-terminal half of Alix/AIP1 was shown by Vito et al.
(4) to impair apoptosis after serum deprivation, and we have recently
observed a similar death-blocking effect of overexpressed Alix-CT in
cerebellar post-mitotic
neurons.2 One mechanism put
forward by Vito et al. (4) to explain this protective effect
was that Alix-CT may sequester ALG-2, which is necessary for death to
occur. However, we have not seen colocalization of ALG-2 with Alix-CT
(not shown). Our demonstration that Alix-CT perturbs intracellular
compartmentalization, possibly by binding to endophilins, begs the
question of how localization and activity of the known actors of the
death program may be affected by this vacuolization.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
regulatory
subunit of the class IA phosphatidylinositol 3-kinase, thereby
inhibiting the phosphatidylinositol 3-kinase activity of the enzyme.
This activity may explain how overexpressing SETA/Ruk induced apoptosis of cultured primary neurons from the peripheral nervous system (8).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
.
SH3p4 corresponds to SH3p4 lacking the
last 37 amino acids, encompassing 60% of the SH3 domain and generated
by using the unique EcoRV site.
SH3p8, which lacks the
C-terminal fragment starting at aa 303, 4 amino acids upstream of the
SH3 domain, was made using the unique SphI site of SH3p8.
PP14
and Alix
PGY were made using the QuikChange site-directed
mutagenesis kit (Stratagene) according to the manufacturer's
instructions. Briefly, two complementary primers were chosen for each
deletion. The desired deletion was located within primers having 16-18
bases of correct sequences on both sides. Each couple of primers was
extended during temperature cycling using Pfu Turbo DNA
polymerase with FLAG-Alix wild type construct as a template. Parental
cDNA was then digested by the DpnI endonuclease, and
newly synthesized mutation-containing cDNA was transformed into
XL1-Blue supercompetent cells. Complementary primers used
for
PP14 variants were
5'-CCAGCCCCAAGAACCATGGTGCTTCCTGCAAACCG-3' and
5'-CGGTTTGCAGGAGCACCATGGTTCTTGGGGCTGG-3'; the deletion extended from
amino acids 748 to 761. The primers used to construct
PGY were
5'-GCCACAGGCTCAGGGATGCCAAATGCCCATGC-3' and
5'-GCATGGGCATTTGGCATCCCTGAGCCTGTGGC-3'; in this case the deletion
extended from amino acids 802 to 813. Alix lacking the proline-rich
domain starting with Pro-717 (
PRD) was generated using a
modification of the QuikChange site-directed mutagenesis kit protocol
(15), which allows the introduction simultaneously of mutations at
multiple sites. Only one 5'-phosphorylated mutagenic primer is required
for a mutation site, and for simultaneous introductions, all primers
need to be located on the same strand. Primers are extended in a PCR
reaction where a Taq DNA ligase is added to repair a DNA
break into the mutated strand. DpnI is added, and two
additional PCR cycles are performed to synthesize strand
complementary to the mutated strand. Using this modified protocol, we introduced two PmeI sites flanking the PRD of
Alix, with primers 5'-CTGCAGCAGAGCATTGCCAGTTTAAACAGCGCTCCTTCAATCCCTC-3' and 5'-CCCCCGCAGCAGTCCTACTATCCACAGCAGTAACGCTGCCACGTGA-3' in FLAG-Alix wild type. The construct was then digested by PmeI and
ligated. The resulting mutant, FLAG-Alix
PRD, lacks a fragment
encompassing proline 717 to proline 867. Finally, a FLAG-Alix-CT
PRD
was generated by deleting the fragment located between the two
PvuII sites in FLAG-Alix
PRD; the deletion extended from
amino acids 10 to 436 of Alix
PRD, giving a construct where the
first 9 amino acids of Alix are linked to the Alix-CT deprived of the
PRD domain.
SH3p4 were subcloned in a bacterial
expression vector (pGEX 6P-2, Amersham Biosciences) in fusion with
glutathione S-transferase (GST). Fusion proteins were
expressed in BL21 purified on GSH-Sepharose and cleaved away from GST
with the PreScission protease according to the manufacturers' instructions.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
SH3p8) was detected in Alix or
Alix-CT immunoprecipitates. Using a similar set of experiments we have
also demonstrated that SH3p4 co-immunoprecipitates with Alix and
Alix-CT (not shown). These findings strongly suggest that Alix and
endophilins bind through a PRD/SH3 interaction.

View larger version (17K):
[in a new window]
Fig. 1.
A, schematic representation of
Alix mutants used in the study. Deletion of Alix
PP14 spans from aa
748 to 761, whereas that of Alix
PGY spans from aa 802 to 813. B, alignments between sequences containing the
endophilin-binding site of mouse Alix, rat synaptojanin 1 (SJ1), and rat germinal center kinase-like kinase
(GLK).

View larger version (23K):
[in a new window]
Fig. 2.
SH3p8 co-immunoprecipitates with the
C-terminal half of Alix through its SH3 domain. HEK 293 cells were
transfected with plasmids coding for FLAG-tagged Alix, Alix-CT, or
Alix-NT together with plasmids coding for Myc-tagged SH3p8 or
SH3p8.
a and b, FLAG-tagged Alix proteins were
immunoprecipitated (IP) with anti-FLAG monoclonal antibody
and blotted onto a nylon membrane. a, the presence of SH3p8
in the immunoprecipitate was tested with an anti-Myc polyclonal
antibody. b, the presence of Alix proteins within the
immunoprecipitates was verified with an anti-FLAG polyclonal antibody.
c, expression levels of the transfected proteins were
controlled in total cell lysates using anti-FLAG and anti-Myc
monoclonal antibodies.
PRD, which lacks the C-terminal PRD, did not bind
full-length SH3p4 (Fig. 3a), and (ii) recombinant
SH3P4,
which is truncated from its SH3 domain, did not bind any forms of Alix
in the same HEK 293 cell extracts (Fig. 3b). We noticed that
Alix PRD contains a 14-amino acid sequence (aa 748-761) highly
homologous to the demonstrated endophilin-binding site of synaptojanin
1 (18) and of the rat germinal center kinase-like kinase (14) (Fig.
1B). This sequence of Alix represents the region of
interaction with the SH3 domain of endophilin, since SH3p4 does not
bind to Alix lacking these amino acids (Alix
PP14 in Fig.
3a). Deletion of other amino acids (802-813) within the PRD
of Alix had no effect on endophilin binding (Alix
PGY in Fig.
3a).

View larger version (66K):
[in a new window]
Fig. 3.
Binding of SH3p4 to full-length and mutated
forms of Alix in overlay assays. 10 µg of proteins from
mock-transfected HEK 293 cells or cells transfected with Alix, Alix-CT,
Alix DPRD, Alix
PP14, or Alix
PGY were run on an 8%
SDS-polyacrylamide gel and, after transfer to a nylon membrane,
overlaid with recombinant Myc-SH3p4 (a) or Myc-
SH3p4
(b). Bound endophilins were revealed using an anti-Myc
monoclonal antibody. c, Alix proteins present in the same
lysates were revealed using the polyclonal anti-Alix antibody.
Black arrows show overexpressed FLAG-tagged Alix and mutated
forms of Alix, whereas the gray arrow points to the
endogenous form of Alix. The molecular mass difference between
overexpressed and endogenous full-length Alix is due to a 26-amino
acid-long tag on the overexpressed proteins.

View larger version (38K):
[in a new window]
Fig. 4.
SH3p4 binds to Alix in brain
homogenates. A, binding of SH3p4 on proteins from HEK
293 cells and from adult mouse brain extracts. 10 µg of proteins were
separated on a 6% SDS-PAGE and blotted onto a nylon membrane that was
then incubated with recombinant SH3p4. On the left panel,
bound endophilin was revealed using an anti-Myc monoclonal antibody; on
the right panel, Alix was revealed with the polyclonal
anti-Alix antibody. B, binding of SH3p4 on the same brain
homogenate as in A, separated by two-dimensional gel
electrophoresis. 200 µg of soluble proteins from a 100,000 × g supernatant were first separated according to their
isoelectric point between pH 3 and 10 and then according to their
molecular mass on an 8% SDS-PAGE. After blotting, the nylon membrane
was incubated with SH3p4, and the bound endophilin was revealed with an
anti-Myc monoclonal antibody (a). The same membrane was
washed for 45 min at 50 °C in TBS, 0.1% Tween 20, and Alix was
revealed using the anti-Alix polyclonal antibody (b).

View larger version (36K):
[in a new window]
Fig. 5.
Cellular localization of overexpressed
full-length and mutated forms of Alix. In HEK 293 cells,
overexpressed Alix, Alix-NT, and Alix-CT proteins were revealed by
immunofluorescence using a polyclonal anti-Alix antibody
(A-E). Bar, 12 µm in D and 10 µm
in all other fields. Overexpressed Alix (A) and Alix-NT
(B) both localize in the cytoplasm and are particularly
enriched at cell edges and protrusions. In contrast, Alix-CT induces
and delineates tubulo-vesicular structures concentrated within the
perinuclear region (C). Confocal analysis demonstrate the
tubulo-vesicular nature of the compartment induced and delineated by
Alix-CT. The bottom part shows a z section
(height: 9.1 µm) along the white line (D).
Tubulo-vesicular structures induced by overexpression of Alix-CT
(E) may affect the ER. Cells were double-labeled for Alix
and for the ER marker, KDEL sequence. Some tubulo-vesicular structures
delineated by Alix (arrows in E) were also
stained by ER marker (arrows in F). DNA labeled
with Hoechst shows the perinuclear localization of the vacuoles
(E). N, nucleus.

View larger version (36K):
[in a new window]
Fig. 6.
Alix and endophilin co-expression in HEK
293. HEK 293 cells were co-transfected with Alix and Myc-tagged
SH3p4 (A and B) or Alix-CT and Myc-tagged SH3p4
(C-G). Transfected cells were immunostained with polyclonal
anti-Alix (A, C, E, and F)
and co-immunostained with anti-Myc monoclonal antibodies to localize
endophilins (B, D, and E) or with
anti-KDEL antibody that stains ER resident proteins (G). In
E, cells were observed with a confocal microscope.
Bar, 10 µm. In co-transfected HEK 293 cells, Alix
(A) perfectly co-localizes with SH3p4 (B).
Endophilin co-expression dramatically enhances the vacuolization effect
of Alix-CT; co-expression of the Alix-CT with full-length SH3p4 leads
to the appearance of large vacuoles around which most of Alix-CT
(C) and some of the endophilin (D) concentrate.
In confocal analysis (E) Alix-CT (red) delineates
a few perfectly spherical vacuoles; SH3p4 (green), even
though concentrated at the periphery of the vacuoles, is also found in
the rest of the cytoplasm. The bottom part of E
shows a z section (height: 19 µm) along the white
line. N, nucleus. Vacuolization induced by
overexpression of Alix-CT and of SH3p4 may affect the endoplasmic
reticulum, as some perinuclear vacuoles delineated by Alix
(arrows in F) were also stained by ER marker
(arrows in G). Arrowheads point to
vacuoles, which are only Alix-positive. DNA was labeled with
Hoechst.
SH3p4 only induced the
formation of tubulo-vesicular structures having the appearance of those
observed in cells expressing only Alix-CT (Fig.
7C). In this paradigm, we
could not detect any co-localization of Alix-CT with
SH3p4 (Fig. 7,
C and D), demonstrating the lack of interaction
between these truncated proteins. This observation suggests that
interaction between Alix-CT and endophilin is necessary for inducing a
very large vacuole phenotype. Alix-CT lacking the PRD (Alix-CT
PRD)
did not cause any vacuolization when overexpressed alone (not shown) or
together with endophilins (Fig. 7, A and B).

View larger version (38K):
[in a new window]
Fig. 7.
A-D, an intact PRD in Alix-CT and an
intact SH3 domain in SH3p4 are required to induce cytoplasmic
vacuolization. HEK 293 cells were co-transfected with FLAG-tagged
Alix-CT
PRD and full-length Myc-tagged SH3p4 (A and
B) or with FLAG-tagged Alix-CT and Myc-tagged
SH3p4
(C and D). The cells were stained with polyclonal
anti-Alix (A and C) together with monoclonal
anti-Myc to reveal endophilin (B and D). PRD
deleted from Alix-CT does not induce cytoplasmic vacuoles (A
and B), and endophilin lacking its SH3 domain (
SH3p4)
does not enhance Alix-CT induced vacuolization; in this case the
tubulo-vesicular structures have the size and appearance of those seen
with Alix-CT alone (C and D). E-H,
Alix-CT-induced vacuoles are insoluble in Triton X-100. HEK 293 cells
were transfected with FLAG-tagged Alix-CT alone (E and
F) or together with Myc-tagged SH3p4 (G and
H). Cells were stained with polyclonal anti-Alix
(E and G) together with monoclonal anti-Myc to
reveal endophilin in H; the staining was performed after a
pretreatment with 1% Triton X-100 for 3 min before
paraformaldehyde fixation. F is a phase contrast
micrograph of the same field as that seen in E. Note in
H that residual SH3p4 is found exclusively around vacuoles
co-localizing with Alix-CT. Bar, 10 µm in all
fields.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1-adrenergic receptor, which should be absent from our
extracts since they are transmembrane proteins (20, 21). They also bind
to the 145-kDa synaptojanin 1 and to two proteins migrating around 100 kDa, dynamin and germinal center kinase-like kinase (12, 14, 19), and
to amphiphysins I and II, migrating around 120 and 80 kDa. We separated
soluble brain extracts on two-dimensional gels to differentiate Alix
from these latter proteins, and we found that the two more acidic, from
three spots recognized by our anti-Alix antibody, bound endophilin.
These Alix forms may reflect different phosphorylation states of the
protein, which is a demonstrated substrate of Src in
Xenopus (22) and contains multiple consensus phosphorylation
sites for Ser/Thr kinases. Of the three forms of Alix, only the two
more acidic ones bound to SH3p4, a finding that may suggest that
endophilin binding depends on post-translational modifications of the protein.
| |
ACKNOWLEDGEMENTS |
|---|
We thank all our friends and colleagues, in particular, Claude Feuerstein for constant support, Fiona Hemming, Jean Marc Verna, Karin Sadoul, and Corinne Albiges-Rizo for comments on the manuscript, and Yves Usson for confocal microscopy analysis.
| |
FOOTNOTES |
|---|
* This work was supported in part by the INSERM, the University Joseph Fourier, and grants from the Association pour la Recherche contre le Cancer and from the Association Française contre les Myopathies.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Laboratoire Neurodégénérescence et Plasticité, EMI 0108, Pavillon de Neurologie, CHU de Grenoble, BP 217, 38043 Grenoble Cedex 9, France. Tel.: 33-4-76-76-88-83; Fax: 3-4-76-76-58-22; E-mail: remy.sadoul@ujf-grenoble.fr.
Published, JBC Papers in Press, May 28, 2002, DOI 10.1074/jbc.M204019200
2 I. M. Verna, S. Torch, and R. Sadoul, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Alix, ALG-2-interacting protein X; ALG-2, apoptosis-linked gene 2; AIP1, ALG-2-interacting protein 1; SH3, Src homology domain 3; PRD, proline-rich domain; SETA, SH3 domain expressed in tumorigenic astrocytes; GST, glutathione S-transferase; ER, endoplasmic reticulum; HEK, human embryonic kidney cells; aa, amino acid(s); TBS, Tris-buffered saline; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Missotten, M., Nichols, A., Rieger, K., and Sadoul, R. (1999) Cell Death Differ 6, 124-129[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Lacana, E., Ganjei, J. K., Vito, P., and D'Adamio, L. (1997) J. Immunol. 158, 5129-5135[Abstract] |
| 3. | Vito, P., Lacana, E., and D'Adamio, L. (1996) Science 271, 521-525[Abstract] |
| 4. |
Vito, P.,
Pellegrini, L.,
Guiet, C.,
and D'Adamio, L.
(1999)
J. Biol. Chem.
274,
1533-1540 |
| 5. |
Xu, W.,
and Mitchell, A. P.
(2001)
J. Bacteriol.
183,
6917-6923 |
| 6. | Babst, M., Wendland, B., Estepa, E. J., and Emr, S. D. (1998) EMBO J. 17, 2982-2993[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Chen, B.,
Borinstein, S. C.,
Gillis, J.,
Sykes, V. W.,
and Bogler, O.
(2000)
J. Biol. Chem.
275,
19275-19281 |
| 8. | Gout, I., Middleton, G., Adu, J., Ninkina, N. N., Drobot, L. B., Filonenko, V., Matsuka, G., Davies, A. M., Waterfield, M., and Buchman, V. L. (2000) EMBO J. 19, 4015-4025[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Borinstein, S. C., Hyatt, M. A., Sykes, V. W., Straub, R. E., Lipkowitz, S., Boulter, J., and Bogler, O. (2000) Cell. Signal. 12, 769-779[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Huttner, W. B., and Schmidt, A. (2000) Curr. Opin. Neurobiol. 10, 543-551[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Schmidt, A., Wolde, M., Thiele, C., Fest, W., Kratzin, H., Podtelejnikov, A. V., Witke, W., Huttner, W. B., and Soling, H. D. (1999) Nature 401, 133-141[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Ringstad, N.,
Nemoto, Y.,
and De Camilli, P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8569-8574 |
| 13. |
Hill, E.,
van Der Kaay, J.,
Downes, C. P.,
and Smythe, E.
(2001)
J. Cell Biol.
152,
309-323 |
| 14. |
Ramjaun, A. R.,
Angers, A.,
Legendre-Guillemin, V.,
Tong, X. K.,
and McPherson, P. S.
(2001)
J. Biol. Chem.
276,
28913-28919 |
| 15. | Sawano, A., and Miyawaki, A. (2000) Nucleic Acids Res. 28, E78[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Sparks, A. B., Hoffman, N. G., McConnell, S. J., Fowlkes, D. M., and Kay, B. K. (1996) Nat. Biotechnol. 14, 741-744[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
de Heuvel, E.,
Bell, A. W.,
Ramjaun, A. R.,
Wong, K.,
Sossin, W. S.,
and McPherson, P. S.
(1997)
J. Biol. Chem.
272,
8710-8716 |
| 18. | Gad, H., Ringstad, N., Low, P., Kjaerulff, O., Gustafsson, J., Wenk, M., Di, Paolo, G., Nemoto, Y., Crun, J., Ellisman, M. H., De, Camilli, P., Shupliakov, O., and Brodin, L. (2000) Neuron 27, 301-312[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Micheva, K. D.,
Kay, B. K.,
and McPherson, P. S.
(1997)
J. Biol. Chem.
272,
27239-27245 |
| 20. |
Howard, L.,
Nelson, K. K.,
Maciewicz, R. A.,
and Blobel, C. P.
(1999)
J. Biol. Chem.
274,
31693-31699 |
| 21. |
Tang, Y., Hu, L. A.,
Miller, W. E.,
Ringstad, N.,
Hall, R. A.,
Pitcher, J. A.,
DeCamilli, P.,
and Lefkowitz, R. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
12559-12564 |
| 22. |
Che, S., El-,
Hodiri, H. M., Wu, C. F.,
Nelman-Gonzalez, M.,
Weil, M. M.,
Etkin, L. D.,
Clark, R. B.,
and Kuang, J.
(1999)
J. Biol. Chem.
274,
5522-5531 |
| 23. |
Cestra, G.,
Castagnoli, L.,
Dente, L.,
Minenkova, O.,
Petrelli, A.,
Migone, N.,
Hoffmuller, U.,
Schneider-Mergener, J.,
and Cesareni, G.
(1999)
J. Biol. Chem.
274,
32001-32007 |
| 24. |
Farsad, K.,
Ringstad, N.,
Takei, K.,
Floyd, S. R.,
Rose, K.,
and De Camilli, P.
(2001)
J. Cell Biol.
155,
193-200 |
| 25. |
Garin, J.,
Diez, R.,
Kieffer, S.,
Dermine, J. F.,
Duclos, S.,
Gagnon, E.,
Sadoul, R.,
Rondeau, C.,
and Desjardins, M.
(2001)
J. Cell Biol.
152,
165-180 |
| 26. |
Thery, C.,
Boussac, M.,
Veron, P.,
Ricciardi-Castagnoli, P.,
Raposo, G.,
Garin, J.,
and Amigorena, S.
(2001)
J. Immunol.
166,
7309-7318 |
This article has been cited by other articles:
![]() |
J. McCullough, R. D. Fisher, F. G. Whitby, W. I. Sundquist, and C. P. Hill ALIX-CHMP4 interactions in the human ESCRT pathway PNAS, June 3, 2008; 105(22): 7687 - 7691. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shibata, H. Suzuki, T. Kakiuchi, T. Inuzuka, H. Yoshida, T. Mizuno, and M. Maki Identification of Alix-type and Non-Alix-type ALG-2-binding Sites in Human Phospholipid Scramblase 3: DIFFERENTIAL BINDING TO AN ALTERNATIVELY SPLICED ISOFORM AND AMINO ACID-SUBSTITUTED MUTANTS J. Biol. Chem., April 11, 2008; 283(15): 9623 - 9632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brunner and M. Merrow The green yeast uses its plant-like clock to regulate its animal-like tail Genes & Dev., April 1, 2008; 22(7): 825 - 831. [Full Text] [PDF] |
||||
![]() |
E. Nikko and B. Andre Split-Ubiquitin Two-Hybrid Assay To Analyze Protein-Protein Interactions at the Endosome: Application to Saccharomyces cerevisiae Bro1 Interacting with ESCRT Complexes, the Doa4 Ubiquitin Hydrolase, and the Rsp5 Ubiquitin Ligase Eukaryot. Cell, August 1, 2007; 6(8): 1266 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Honeychurch, G. Yang, R. Jordan, and D. E. Hruby The Vaccinia Virus F13L YPPL Motif Is Required for Efficient Release of Extracellular Enveloped Virus J. Virol., July 1, 2007; 81(13): 7310 - 7315. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Usami, S. Popov, and H. G. Gottlinger Potent Rescue of Human Immunodeficiency Virus Type 1 Late Domain Mutants by ALIX/AIP1 Depends on Its CHMP4 Binding Site J. Virol., June 15, 2007; 81(12): 6614 - 6622. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yi, R. Bouley, H. Y. Lin, S. Bechoua, T.-x. Sun, E. del Re, T. Shioda, M. K. Raychowdhury, H. A. J. Lu, A. B. Abou-Samra, et al. Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1303 - F1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Munshi, J. Kim, K. Nagashima, J. H. Hurley, and E. O. Freed An Alix Fragment Potently Inhibits HIV-1 Budding: CHARACTERIZATION OF BINDING TO RETROVIRAL YPXL LATE DOMAINS J. Biol. Chem., February 9, 2007; 282(6): 3847 - 3855. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamasaki, K. Tani, A. Yamamoto, N. Kitamura, and M. Komada The Ca2+-binding Protein ALG-2 Is Recruited to Endoplasmic Reticulum Exit Sites by Sec31A and Stabilizes the Localization of Sec31A Mol. Biol. Cell, November 1, 2006; 17(11): 4876 - 4887. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Odorizzi The multiple personalities of Alix. J. Cell Sci., August 1, 2006; 119(Pt 15): 3025 - 3032. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Stewart, J. T. White, X. Yan, S. Collins, C. W. Drescher, N. D. Urban, L. Hood, and B. Lin Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with mRNA Expression Levels Mol. Cell. Proteomics, March 1, 2006; 5(3): 433 - 443. [Abstract] |